Table 1 Serial analysis of complete blood count, temperature, inflammatory markers, and cardiac biomarkers
Days from clopidogrel use | Management | T (C) | WBC (× 103/mm3) | ANC (× 103/mm3) | Hb (g/dL) | PLT (× 103/mm3) | CRP (mg/dL) | hsTnI (ng/mL) | BNP (pg/mL) |
|---|---|---|---|---|---|---|---|---|---|
37 | 36.8 | 7.50 | 5.55 | 9.9 | 164 | – | – | 1030.11 | |
51 | Normal | 2.5 | 1.0 | 13.4 | 137 | – | – | – | |
55 | Discontinued clopidogrel; started ticagrelor, G-CSF, and IV imipenem/cilastatin | 39.0 | 0.84 | 0.13 | 9.0 | 137 | 18.4 | 0.14 | 1130.69 |
56 | – | 1.26 | 0.29 | 8.6 | 111 | – | 0.11 | 295.4 | |
57 | 36.5 | 1.77 | 0.86 | 8.5 | 124 | – | – | – | |
58 | Discontinued G-CSF and imipenem/cilastatin; started oral moxifloxacin | 36.5 | 4.64 | 3.53 | 9.0 | 133 | 8.4 | – | – |
60 | 36.3 | 11.68 | 9.71 | 9.6 | 189 | 3.4 | 0.06 | 759.22 | |
62 | Discontinued moxifloxacin | 36.4 | 6.11 | 4.62 | 10.6 | 207 | – | 0.05 | 961.65 |
64 | Discharged | 36.2 | 7.36 | 5.93 | 10.4 | 233 | – | – | – |
77 | Follow-up | Normal | 4.0 | 2.3 | 12.2 | 165 | – | – | – |
122 | Follow-up | Normal | 6.7 | 4.7 | 13.5 | 137 | – | – | – |